Total Funding
95
81
Total FundingPost-IPO Debt raised
Growth Score
6 pts
Heat Score
49 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
41610
Bachem Holding AG is an independent, technology-based, public biochemicals company.
- Pascal Degen: Vice President Global Supply Chain Management
Dirk BÄChle: Director Quality Control II
About the Company
Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry.
Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes.
Bachem has more than 40 years of experience in peptide research
Excellent know-how in peptide chemistry and organic synthesis (technology leadership)
Efficient manufacturing processes (cost leadership)
Bachem sets industry standards
With headquarters in Bubendorf, Switzerland and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of peptides.
